SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-006385
Filing Date
2022-01-11
Accepted
2022-01-11 09:00:46
Documents
53
Period of Report
2022-01-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d290042d8k.htm   iXBRL 8-K 28305
2 EX-99.1 d290042dex991.htm EX-99.1 25541
3 EX-99.2 d290042dex992.htm EX-99.2 36884
7 GRAPHIC g290042ex99_2s10g1.jpg GRAPHIC 321028
8 GRAPHIC g290042ex99_2s11g1.jpg GRAPHIC 201368
9 GRAPHIC g290042ex99_2s12g1.jpg GRAPHIC 409021
10 GRAPHIC g290042ex99_2s13g1.jpg GRAPHIC 231393
11 GRAPHIC g290042ex99_2s14g1.jpg GRAPHIC 226077
12 GRAPHIC g290042ex99_2s15g1.jpg GRAPHIC 151666
13 GRAPHIC g290042ex99_2s16g1.jpg GRAPHIC 261784
14 GRAPHIC g290042ex99_2s17g1.jpg GRAPHIC 263398
15 GRAPHIC g290042ex99_2s18g1.jpg GRAPHIC 198496
16 GRAPHIC g290042ex99_2s19g1.jpg GRAPHIC 282545
17 GRAPHIC g290042ex99_2s1g1.jpg GRAPHIC 115134
18 GRAPHIC g290042ex99_2s20g1.jpg GRAPHIC 158374
19 GRAPHIC g290042ex99_2s21g1.jpg GRAPHIC 280610
20 GRAPHIC g290042ex99_2s22g1.jpg GRAPHIC 253780
21 GRAPHIC g290042ex99_2s23g1.jpg GRAPHIC 113793
22 GRAPHIC g290042ex99_2s24g1.jpg GRAPHIC 318447
23 GRAPHIC g290042ex99_2s25g1.jpg GRAPHIC 200960
24 GRAPHIC g290042ex99_2s26g1.jpg GRAPHIC 258010
25 GRAPHIC g290042ex99_2s27g1.jpg GRAPHIC 282445
26 GRAPHIC g290042ex99_2s28g1.jpg GRAPHIC 316552
27 GRAPHIC g290042ex99_2s29g1.jpg GRAPHIC 323209
28 GRAPHIC g290042ex99_2s2g1.jpg GRAPHIC 520802
29 GRAPHIC g290042ex99_2s30g1.jpg GRAPHIC 329266
30 GRAPHIC g290042ex99_2s31g1.jpg GRAPHIC 340308
31 GRAPHIC g290042ex99_2s32g1.jpg GRAPHIC 118139
32 GRAPHIC g290042ex99_2s33g1.jpg GRAPHIC 174577
33 GRAPHIC g290042ex99_2s34g1.jpg GRAPHIC 277383
34 GRAPHIC g290042ex99_2s35g1.jpg GRAPHIC 221523
35 GRAPHIC g290042ex99_2s36g1.jpg GRAPHIC 369009
36 GRAPHIC g290042ex99_2s37g1.jpg GRAPHIC 132901
37 GRAPHIC g290042ex99_2s38g1.jpg GRAPHIC 258178
38 GRAPHIC g290042ex99_2s3g1.jpg GRAPHIC 368914
39 GRAPHIC g290042ex99_2s4g1.jpg GRAPHIC 229444
40 GRAPHIC g290042ex99_2s5g1.jpg GRAPHIC 300603
41 GRAPHIC g290042ex99_2s6g1.jpg GRAPHIC 312567
42 GRAPHIC g290042ex99_2s7g1.jpg GRAPHIC 178203
43 GRAPHIC g290042ex99_2s8g1.jpg GRAPHIC 287470
44 GRAPHIC g290042ex99_2s9g1.jpg GRAPHIC 324870
45 GRAPHIC g290042snap0001.jpg GRAPHIC 7420
  Complete submission text file 0001193125-22-006385.txt   13903379

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mirm-20220111.xsd EX-101.SCH 2888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20220111_lab.xml EX-101.LAB 18887
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20220111_pre.xml EX-101.PRE 11857
47 EXTRACTED XBRL INSTANCE DOCUMENT d290042d8k_htm.xml XML 3498
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 22522843
SIC: 2834 Pharmaceutical Preparations